Core Viewpoint - The foreign exchange market in China continues to operate steadily despite increased volatility and differentiation in the international financial market, with stable net inflows in securities investment [1] Group 1: Foreign Exchange Data - In January 2026, banks settled foreign exchange transactions amounting to 20,048 billion RMB and sold 14,457 billion RMB, equivalent to 2,863 billion USD and 2,065 billion USD respectively [1] - The foreign exchange income from banks for clients was 54,722 billion RMB, while foreign payments were 48,974 billion RMB, translating to 7,816 billion USD and 6,995 billion USD respectively [1] Group 2: Cross-Border Capital Flows - Cross-border capital maintained a net inflow, although the scale decreased compared to the previous month, with bank settlement and sale surplus and net inflows from non-bank sectors dropping by 20% and 28% respectively [1] - The net inflow of funds under goods trade decreased by 27% compared to the previous month, while net outflows under service trade increased by 23%, with securities investment remaining stable [1] Group 3: Market Stability - Overall, the foreign exchange market in China is characterized by active trading and stable expectations, with cross-border capital flows becoming more stable [1]

（原标题：2025年巴西接收的直接投资（IDP）净值达到770亿美元，为2018年以来的最高水平） 巴西央行近日公布的统计数据显示，2025年巴西接收的直接投资（IDP）净值达到770亿美元，这 是自2018年以来的最高水平。央行数据显示，一个国家所接收到的直接投资反映的是以长期收益为目的 的资本流入和流出情况，涵盖商业投资、企业设立、跨国公司开设分支机构、基础设施建设、新工厂投 建、收购本国企业股权等经济活动。央行数据显示，2025年，股权投资的净流入金额为624亿美元，同 比下降3.5%；国内市场的证券投资（投资组合）实现153亿美元的净流入，其中股票和投资基金净流出 49亿美元，而债券类资产实现净流入202亿美元。 ...

Core Viewpoint - Mingke International (08100) anticipates a profit of approximately HKD 10.8 million from its securities investment segment for the fiscal year ending December 31, 2025, compared to an estimated profit of about HKD 5.193 million for the fiscal year ending December 31, 2024 [1] Financial Performance - The expected profit for the securities investment segment in the fiscal year 2025 is primarily attributed to realized and unrealized gains from financial assets measured at fair value through profit or loss, amounting to approximately HKD 10.734 million [1] - For the fiscal year 2024, the realized and unrealized gains were approximately HKD 5.045 million [1]

Core Viewpoint - The company plans to utilize idle funds for entrusted wealth management and securities investment, with a total amount not exceeding RMB 2.9 billion, to enhance the efficiency of fund usage and generate returns for shareholders [2][3][14]. Investment Overview - Investment Purpose: The company aims to improve the efficiency of idle funds while ensuring normal business operations and daily capital needs [3]. - Total Investment Amount: The total investment amount will not exceed RMB 2.9 billion, with RMB 2.3 billion allocated for entrusted wealth management and RMB 600 million for securities investment [2][3][14]. - Investment Duration: The investment period is set for 12 months from the approval date of the board meeting [4][14]. Investment Details - Source of Funds: The funds will come from the company's idle self-owned capital [4]. - Investment Methods: Entrusted wealth management will focus on bank wealth management products, income certificates, and funds, while securities investment will include government bonds, bond repurchase agreements, ETFs, and stocks [4][3]. - Approval Process: The investment plan has been approved by the company's board of directors and does not require shareholder meeting approval [6][14]. Impact on the Company - The use of idle funds for wealth management and securities investment will not affect the company's normal cash flow or operations, and it aims to enhance fund returns and protect shareholder interests [8][14]. - Accounting Treatment: The company will account for the entrusted wealth management and securities investment in accordance with relevant accounting standards, reflecting them in the balance sheet and income statement [8].

Core Viewpoint - Chenxin Pharmaceutical (603367) announced plans to utilize idle funds for entrusted wealth management and securities investment, with a total amount not exceeding 2.9 billion yuan, aiming to enhance the efficiency of fund usage and generate higher returns for shareholders [1] Group 1: Investment Plans - The company and its subsidiaries plan to use idle self-owned funds for entrusted wealth management and securities investment, with a total limit of 2.9 billion yuan, including up to 2.3 billion yuan for entrusted wealth management and up to 600 million yuan for securities investment [1] - The investment aims to improve the efficiency of idle funds while ensuring that the company's main business operations and daily capital needs are not affected [1] Group 2: Investment Types - Entrusted wealth management will primarily involve bank wealth management products, income certificates, and funds from financial institutions [1] - Securities investment will focus on government bonds or reverse repos, bonds, ETFs, stocks, and other investments permitted by laws and regulations [1]

Core Viewpoint - The company announced plans to utilize idle self-owned funds for entrusted wealth management and securities investment, with a total amount not exceeding 2.9 billion yuan [1] Group 1: Financial Allocation - The total amount for entrusted wealth management is capped at 2.3 billion yuan [1] - The total amount for securities investment is capped at 600 million yuan [1] - The duration for utilizing these funds is set for 12 months from the date of board approval [1]

格隆汇1月5日丨辰欣药业(603367.SH)公布，公司及控股子公司拟使用闲置自有资金进行委托理财及证 券投资，合计额度不超过人民币29亿元（含），其中委托理财的额度不超过人民币23亿元（含），证券 投资的额度不超过人民币6亿元（含）。资金额度使用期限为自本次董事会审议通过本议案之日起12个 月。 ...

格隆汇1月5日丨辰欣药业(603367.SH)公布，公司及控股子公司拟使用闲置自有资金进行委托理财及证 券投资，合计额度不超过人民币29亿元（含），其中委托理财的额度不超过人民币23亿元（含），证券 投资的额度不超过人民币6亿元（含）。资金额度使用期限为自本次董事会审议通过本议案之日起12个 月。 ...

格隆汇1月4日丨华联控股(000036.SZ)公布，根据公司最新的资金使用计划，公司拟终止使用自有资金 进行证券投资业务。2025年，公司证券投资主要通过沪港通进行港股投资与交易，其中第四季度以净卖 出操作为主。截至2025年12月30日，证券投资账户中现金资产占比约为90%，所持有的少量港股有价证 券拟于近期减持完毕。 ...

Group 1 - The company held its sixth board meeting on December 23, 2025, with all seven directors present, and the meeting was conducted in accordance with relevant laws and regulations [2][3][4] - The board approved several proposals, including the use of idle funds for entrusted wealth management and securities investment for the year 2026, with unanimous support from all directors [3][4][6][7][9] Group 2 - The company plans to utilize idle funds for entrusted wealth management, with a maximum daily balance of RMB 2.6 billion, focusing on low-risk financial products issued by licensed financial institutions [18][20][21] - The investment period for the entrusted wealth management is set from January 1, 2026, to December 31, 2026, not exceeding 12 months [22][24] - The company aims to enhance the efficiency of fund utilization and increase returns on self-owned funds through these investments [19][27] Group 3 - The company also approved a proposal for securities investment, with the same maximum daily balance of RMB 2.6 billion, covering various investment types including stock investments and bond investments [32][34][35] - The investment period for securities investment is also from January 1, 2026, to December 31, 2026, not exceeding 12 months [36][38] - The company emphasizes a cautious investment approach to ensure operational safety while increasing cash asset returns [41] Group 4 - The company plans to conduct external donations totaling RMB 13.45 million in 2026 to support public welfare and rural revitalization projects [42][43] - This initiative is part of the company's commitment to corporate social responsibility and is expected to enhance its social image and brand influence [43] Group 5 - The company announced changes in its financial leadership, with the appointment of a new financial officer, Zhang Yang, following the departure of the previous officer due to work adjustments [46][48] - The company also appointed a new board secretary, Jian Xia, who has extensive experience and qualifications for the role [51][53][56]